Published in Hum Mol Genet on May 23, 2009
Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol (2010) 3.09
Mechanisms of trinucleotide repeat instability during human development. Nat Rev Genet (2010) 2.67
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J (2009) 2.66
Transcription as a source of genome instability. Nat Rev Genet (2012) 1.94
Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS Genet (2009) 1.37
Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease. Cell (2015) 1.33
Huntington's disease: the case for genetic modifiers. Genome Med (2009) 1.25
A novel approach to investigate tissue-specific trinucleotide repeat instability. BMC Syst Biol (2010) 1.20
Xpa deficiency reduces CAG trinucleotide repeat instability in neuronal tissues in a mouse model of SCA1. Hum Mol Genet (2011) 1.12
Convergent transcription through a long CAG tract destabilizes repeats and induces apoptosis. Mol Cell Biol (2010) 1.12
Somatic mosaicism: implications for disease and transmission genetics. Trends Genet (2015) 1.08
Somatic genome variations in health and disease. Curr Genomics (2010) 1.04
18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. Eur J Nucl Med Mol Imaging (2012) 1.03
MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington's disease mice. PLoS Genet (2013) 1.02
Transcription elongation and tissue-specific somatic CAG instability. PLoS Genet (2012) 1.01
Continuous and periodic expansion of CAG repeats in Huntington's disease R6/1 mice. PLoS Genet (2010) 0.99
Genetics and neuropathology of Huntington's disease. Int Rev Neurobiol (2011) 0.99
Nucleotide excision repair, mismatch repair, and R-loops modulate convergent transcription-induced cell death and repeat instability. PLoS One (2012) 0.97
Transcription-induced DNA toxicity at trinucleotide repeats: double bubble is trouble. Cell Cycle (2011) 0.97
Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice. Hum Mol Genet (2012) 0.96
Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches. PLoS Genet (2013) 0.95
Single cell genomics of the brain: focus on neuronal diversity and neuropsychiatric diseases. Curr Genomics (2012) 0.94
Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data. Mov Disord (2013) 0.94
Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington's Disease. PLoS Genet (2015) 0.92
The nucleotide sequence, DNA damage location, and protein stoichiometry influence the base excision repair outcome at CAG/CTG repeats. Biochemistry (2012) 0.91
Quantification of age-dependent somatic CAG repeat instability in Hdh CAG knock-in mice reveals different expansion dynamics in striatum and liver. PLoS One (2011) 0.90
A brief history of triplet repeat diseases. Methods Mol Biol (2013) 0.88
Hypothesis: somatic mosaicism and Parkinson disease. Exp Neurobiol (2014) 0.87
Correlation of inter-locus polyglutamine toxicity with CAG•CTG triplet repeat expandability and flanking genomic DNA GC content. PLoS One (2011) 0.86
DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases. Ann Neurol (2016) 0.84
Huntington's disease mouse models online: high-resolution MRI images with stereotaxic templates for computational neuroanatomy. PLoS One (2012) 0.83
Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice. PLoS One (2012) 0.83
RNA pathogenesis via Toll-like receptor-activated inflammation in expanded repeat neurodegenerative diseases. Front Mol Neurosci (2013) 0.81
Response to Falush: a role for cis-element polymorphisms in HD. Am J Hum Genet (2009) 0.80
Modelling and inference reveal nonlinear length-dependent suppression of somatic instability for small disease associated alleles in myotonic dystrophy type 1 and Huntington disease. J R Soc Interface (2013) 0.79
Disease-associated CAG·CTG triplet repeats expand rapidly in non-dividing mouse cells, but cell cycle arrest is insufficient to drive expansion. Nucleic Acids Res (2014) 0.78
Instability of the octarepeat region of the human prion protein gene. PLoS One (2011) 0.78
The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease. Mech Ageing Dev (2016) 0.77
Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases? Front Psychiatry (2015) 0.77
Ribonucleotides and Transcription-Associated Mutagenesis in Yeast. J Mol Biol (2016) 0.77
Mismatch repair enhances convergent transcription-induced cell death at trinucleotide repeats by activating ATR. DNA Repair (Amst) (2016) 0.76
Problems and solutions for the analysis of somatic CAG repeat expansion and their relationship to Huntington's disease toxicity. Rare Dis (2016) 0.76
DNA dynamics is likely to be a factor in the genomic nucleotide repeats expansions related to diseases. PLoS One (2011) 0.76
Abnormal base excision repair at trinucleotide repeats associated with diseases: a tissue-selective mechanism. Genes (Basel) (2013) 0.76
Expansion, mosaicism and interruption: mechanisms of the CAG repeat mutation in spinocerebellar ataxia type 1. Cerebellum Ataxias (2016) 0.75
Ethidium Bromide Modifies The Agarose Electrophoretic Mobility of CAG•CTG Alternative DNA Structures Generated by PCR. Front Cell Neurosci (2017) 0.75
Close encounters: Moving along bumps, breaks, and bubbles on expanded trinucleotide tracts. DNA Repair (Amst) (2017) 0.75
Tics as an initial manifestation of juvenile Huntington's disease: case report and literature review. BMC Neurol (2017) 0.75
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet (1993) 6.53
The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet (1993) 5.82
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70
Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry (2007) 5.49
A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes (1993) 3.76
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A (2004) 3.73
OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature (2007) 3.03
Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat Genet (1999) 2.77
(CAG)(n)-hairpin DNA binds to Msh2-Msh3 and changes properties of mismatch recognition. Nat Struct Mol Biol (2005) 2.71
CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. Science (2007) 2.45
Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain (2008) 2.40
Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet (1994) 2.31
Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum Mol Genet (1999) 2.20
Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet (1993) 2.00
Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum Mol Genet (2003) 1.96
Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum. Hum Mol Genet (2003) 1.92
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am J Hum Genet (2003) 1.85
Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease. Proc Natl Acad Sci U S A (1997) 1.75
DNA instability in postmitotic neurons. Proc Natl Acad Sci U S A (2008) 1.61
Evidence for the GluR6 gene associated with younger onset age of Huntington's disease. Neurology (1999) 1.60
Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? Hum Mol Genet (2000) 1.58
Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes. Neurobiol Dis (2008) 1.58
Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Hum Mol Genet (2007) 1.57
The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proc Natl Acad Sci U S A (2001) 1.51
Somatic instability of CTG repeat in myotonic dystrophy. Neurology (1993) 1.49
Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J Med Genet (2006) 1.42
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Med Genet (2006) 1.30
Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease. Neurosci Lett (2002) 1.28
Dramatic, expansion-biased, age-dependent, tissue-specific somatic mosaicism in a transgenic mouse model of triplet repeat instability. Hum Mol Genet (2000) 1.25
Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease. Hum Mol Genet (2008) 1.23
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16. Neurogenetics (2004) 1.19
Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India. Neurosci Lett (2003) 1.12
Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds. Genet Epidemiol (2008) 1.06
The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease. Neurogenetics (2005) 1.06
CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain. Neuron (1995) 1.05
Huntington's disease. Cold Spring Harb Symp Quant Biol (1996) 1.02
Analysis of unstable triplet repeats using small-pool polymerase chain reaction. Methods Mol Biol (2004) 1.01
Regional differences of somatic CAG repeat instability do not account for selective neuronal vulnerability in a knock-in mouse model of SCA1. Hum Mol Genet (2003) 1.00
Inherited CAG.CTG allele length is a major modifier of somatic mutation length variability in Huntington disease. DNA Repair (Amst) (2007) 0.96
Somatic expansion of the (CAG)n repeat in Huntington disease brains. Hum Genet (1995) 0.93
Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene. Eur J Neurol (2007) 0.91
A universal mechanism ties genotype to phenotype in trinucleotide diseases. PLoS Comput Biol (2007) 0.85
Huntington's disease: a clinical, genetic and molecular model for polyglutamine repeat disorders. Philos Trans R Soc Lond B Biol Sci (1999) 0.85
DNA instability in replicating Huntington's disease lymphoblasts. BMC Med Genet (2009) 0.80
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell (2011) 6.56
Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet (2008) 5.04
Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell (2013) 4.45
Retracted Genetic signatures of exceptional longevity in humans. Science (2010) 4.33
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
The UK10K project identifies rare variants in health and disease. Nature (2015) 3.89
A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet (2009) 3.78
Genetic signatures of exceptional longevity in humans. PLoS One (2012) 3.20
Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. Ann Neurol (2012) 2.20
Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature (2010) 2.10
The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med (2008) 2.10
A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes (2002) 1.99
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet (2005) 1.96
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol (2006) 1.94
Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3. Am J Hum Genet (2005) 1.94
A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am J Hum Genet (2003) 1.85
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Hum Mol Genet (2003) 1.72
Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet (2001) 1.59
Intergenerational and striatal CAG repeat instability in Huntington's disease knock-in mice involve different DNA repair genes. Neurobiol Dis (2008) 1.58
Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med (2012) 1.49
Genetic loci influencing lung function: a genome-wide scan in the Framingham Study. Am J Respir Crit Care Med (2002) 1.47
Linkage of the cholesterol 7alpha-hydroxylase gene and low-density lipoprotein cholesterol conditional on apolipoprotein E association: the National Heart, Lung, and Blood Institute Family Heart Study. Chin Med J (Engl) (2005) 1.42
Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord (2008) 1.41
Genomewide linkage analysis to presbycusis in the Framingham Heart Study. Arch Otolaryngol Head Neck Surg (2003) 1.38
Stoichiometry of base excision repair proteins correlates with increased somatic CAG instability in striatum over cerebellum in Huntington's disease transgenic mice. PLoS Genet (2009) 1.37
Genetic variability of adult body mass index: a longitudinal assessment in framingham families. Obes Res (2002) 1.34
Huntingtin facilitates polycomb repressive complex 2. Hum Mol Genet (2009) 1.32
Retraction. Science (2011) 1.32
Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice. Hum Mol Genet (2006) 1.32
Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Med Genet (2006) 1.30
The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Ann Hum Genet (2006) 1.26
Considerations for genomewide association studies in Parkinson disease. Am J Hum Genet (2006) 1.26
Linkage analysis of a composite factor for the multiple metabolic syndrome: the National Heart, Lung, and Blood Institute Family Heart Study. Diabetes (2003) 1.24
Genomewide association study for onset age in Parkinson disease. BMC Med Genet (2009) 1.24
Huntington's disease. Neuromolecular Med (2003) 1.22
Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse. Am J Hum Genet (2001) 1.21
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol (2007) 1.21
A novel approach to investigate tissue-specific trinucleotide repeat instability. BMC Syst Biol (2010) 1.20
A genome-wide scan of pulmonary function measures in the National Heart, Lung, and Blood Institute Family Heart Study. Am J Respir Crit Care Med (2003) 1.19
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet (2002) 1.19
Evidence for a modifier of onset age in Huntington disease linked to the HD gene in 4p16. Neurogenetics (2004) 1.19
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLoS Med (2013) 1.18
Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder. Am J Psychiatry (2010) 1.16
Linkage and association with pulmonary function measures on chromosome 6q27 in the Framingham Heart Study. Hum Mol Genet (2003) 1.14
Genetic effect on blood pressure is modulated by age: the Hypertension Genetic Epidemiology Network Study. Hypertension (2008) 1.10
LRRK2 is not a significant cause of Parkinson's disease in French-Canadians. Can J Neurol Sci (2007) 1.09
Longitudinal and age trends of metabolic syndrome and its risk factors: the Family Heart Study. Nutr Metab (Lond) (2006) 1.08
Human-specific histone methylation signatures at transcription start sites in prefrontal neurons. PLoS Biol (2012) 1.08
Common SNP-based haplotype analysis of the 4p16.3 Huntington disease gene region. Am J Hum Genet (2012) 1.05
Early alterations of brain cellular energy homeostasis in Huntington disease models. J Biol Chem (2011) 1.05
A genome-wide scan for loci affecting normal adult height in the Framingham Heart Study. Hum Hered (2003) 1.04
Identification of a presymptomatic molecular phenotype in Hdh CAG knock-in mice. Hum Mol Genet (2002) 1.03
Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG). Am J Med Genet A (2009) 1.03
Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice. Neurobiol Dis (2006) 1.03
Copy number variation in familial Parkinson disease. PLoS One (2011) 1.02
Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol (2004) 1.01
Assessment of cortical and striatal involvement in 523 Huntington disease brains. Neurology (2012) 1.00
HaploBuild: an algorithm to construct non-contiguous associated haplotypes in family based genetic studies. Bioinformatics (2007) 0.98
Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: the NHLBI Family Heart Study follow-up examination. Atherosclerosis (2007) 0.97
An evaluation of the metabolic syndrome in the HyperGEN study. Nutr Metab (Lond) (2005) 0.97
State of the art review: molecular diagnosis of inherited movement disorders. Movement Disorders Society task force on molecular diagnosis. Mov Disord (2003) 0.96
Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study. Stroke (2002) 0.96
Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington's disease mice: genome-wide and candidate approaches. PLoS Genet (2013) 0.95
Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington's disease. Neurobiol Dis (2006) 0.95
Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study. Hypertension (2009) 0.94
Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation. PLoS Genet (2012) 0.94
Genetic associations with expression for genes implicated in GWAS studies for atherosclerotic cardiovascular disease and blood phenotypes. Hum Mol Genet (2013) 0.93
Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease. Exp Neurol (2010) 0.92
Large-scale phenotyping of an accurate genetic mouse model of JNCL identifies novel early pathology outside the central nervous system. PLoS One (2012) 0.92
Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study. Hum Mol Genet (2011) 0.91
Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet (2008) 0.91
A genome-wide screen reveals evidence for a locus on chromosome 11 influencing variation in LDL cholesterol in the NHLBI Family Heart Study. Hum Genet (2002) 0.91
Quantification of age-dependent somatic CAG repeat instability in Hdh CAG knock-in mice reveals different expansion dynamics in striatum and liver. PLoS One (2011) 0.90
A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice. PLoS One (2013) 0.89